SEC Tracker
Get the app

Bausch Health Companies BHC

Bausch Health Companies: signs a material agreement, completes an acquisition or sale of assets and takes on a new financial obligation

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.1
Material contract
Exhibit 99.1
Press release
  • Signs a material agreement (1.01)
  • Completes an acquisition or sale of assets (2.01)
  • Takes on a new financial obligation (2.03)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Bausch Health Companies files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Recursion Pharmaceuticals RXRX public float $2.0B, Jun 30, 2025
  2. Agios Pharmaceuticals AGIO public float $1.9B, Jun 30, 2025
  3. Vericel VCEL public float $2.1B, Jun 30, 2025
  4. Biocryst Pharmaceuticals BCRX public float $1.9B, Jun 30, 2025
  5. Indivior Pharmaceuticals INDV public float $1.8B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.